Physician profile
Christopher Grove
NPI 1306838545
$19,201.64
in general payments reported to CMS, 2019-2025
15 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.13 · 2020: $22.51 · 2021: $917 · 2022: $165 · 2023: $378 · 2024: $4,896 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Honoraria: $4,500 · Travel and Lodging: $1,210 · Food and Beverage: $686 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,434.00 |
| Honoraria | $4,500.00 |
| Travel and Lodging | $1,210.00 |
| Food and Beverage | $685.68 |
| Education | $234.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $17,442.09 | 2024-2025 | |
| Medical Device Business Services, INC. | $878.95 | 2021 | |
| Davol INC. | $296.68 | 2020-2025 | Phasix Mesh |
| Dilon Technologies, INC. | $118.13 | 2024 | Hemoblast Bellows |
| Endomagnetics Ltd | $112.80 | 2022 | |
| Guard Medical INC. | $100.00 | 2023 | Npseal Medium, Npseal (5), Npseal Large |
| Heron Therapeutics, INC. | $59.64 | 2021-2023 | Zynrelef |
| Aroa Biosurgery Incorporated | $36.08 | 2022-2024 | |
| Boston Scientific Corporation | $30.20 | 2024 | Spyglass Discover |
| Ethicon US, LLC | $25.17 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $24.27 | 2024 | |
| Kerecis Limited | $22.16 | 2021 | |
| Smith+Nephew, INC. | $22.03 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.59 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Grove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.